We would love to hear your thoughts about our site and services, please take our survey here.
From Christina’s presentation.
And so our conclusions from these data, the first, AVA6000, is essentially doing what it was designed to do. It delivers high concentrations of doxorubicin to the tumour microenvironment relative to plasma concentration, and that results in significant anti-tumour activity in those patients whose tumours have high overexpression of FAP.
AVA6000 has a very distinct safety profile, which is different from doxorubicin. We have significant reductions in both severe and mild to moderate toxicities that are associated with standard dose doxorubicin.
Our exposure response modeling suggests that released doxorubicin is generated primarily by cleavage in the tumor microenvironment as opposed to soluble FAP in the bloodstream, important for the precision platform as this is the proof of mechanism, of the platform in the clinic.
None of them as large as the 2 million buy @1.94
4 x daily average , people are taking positions
Many have slated AS in recent months for his commercial acumen and his communication ability when it comes to sharing news and keeping the market updated, however it is clear , when it comes to the world of oncology both AS and Avacta have an established and growing strong reputation and credibility. This is clearly reflected in today’s announcements of some highly reputable and credible additions in the field of oncology.
It’s interesting that Myles published this update in super quick time after his meeting last week with the company , combine that with the bullish tone of the update and conclusion is that positive progress is coming and coming very soon
It states nose swab only , but doesn’t state if it’s anterior or posterior , I got excited because it was an observed test ( professional use ) and nose swab only , but as you rightly point out it’s probably Orient Gene
MMs could have fun with this either way , hold on to your shares , rewards will come over the next few weeks , Rome wasn’t build in a day .
MMs filling big orders again I suspect and taking the price down until they get enough sellers , this will bounce back when the big orders are filled
This was at 77.75 @ 9.00am Monday and finishes at 89! That’s almost a 14.5% growth in 5 days , I’d take that every week , but hope it’s a lot more by this time next week !!
To get your bargain price before a big week ahead , just taken some with what cash I had left